Multilocular cystic renal neoplasm of low malignant potential (MCRNLMP) is a cystic renal tumor with indolent clinical behavior. In most of cases, it is an incidental finding during the examination of other health issues. The true incidence rate is estimated to be between 1.5% and 4% of all RCCs. These lesions are classified according to the Bosniak classification as Bosniak category III. There is a wide spectrum of diagnostic tools that can be utilized in the identification of this tumor, such as computed tomography (CT), magnetic resonance (MRI) or contrast-enhanced ultrasonography (CEUS). Management choices of these lesions range from conservative approaches, such as clinical follow-up, to surgery. Minimally invasive techniques (i.e., robotic surgery and laparoscopy) are preferred, with an emphasis on nephron sparing surgery, if clinically feasible.

Department of Pathology Faculty of Medicine University of British Columbia Royal Columbian Hospital Vancouver BC V6T 1Z4 Canada

Department of Radiology Faculty Hospital in Pilsen Charles University Prague 30599 Pilsen Czech Republic

Department of Urology Faculty Hospital in Pilsen Charles University Prague 30599 Pilsen Czech Republic

Sikl's Department of Pathology Faculty Hospital in Pilsen Charles University Prague 30599 Pilsen Czech Republic

Zobrazit více v PubMed

Lewis R.H., Clark M.A., Dobson C.L., O’Connell K.J. Multilocular cystic renal adenocarcinoma arising in a solitary kidney. J Urol. 1982;127:314–316. doi: 10.1016/S0022-5347(17)53758-1. PubMed DOI

Murad T., Komaiko W., Oyasu R., Bauer K. Multilocular cystic renal cell carcinoma. Am. J. Clin. Pathol. 1991;95:633–637. doi: 10.1093/ajcp/95.5.633. PubMed DOI

Corica F.A., Iczkowski K.A., Cheng L., Zincke H., Blute M.L., Wendel A., Sebo T.J., Neumann R., Botswick D.G. Cystic renal cell carcinoma is cured by resection: A study of 24 cases with long-term followup. J. Urol. 1999;161:408–411. doi: 10.1016/S0022-5347(01)61903-7. PubMed DOI

Kristiansen G., Delahunt B., Srigley J.R., Lüders C., Lunkenheimer J.M., Gevensleben H., Thiesler T., Montironi R., Egevad L. Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP) Der Pathol. 2015;36:310–316. PubMed

Srigley J.R., Delahunt B., Eble J.N., Egevad L., Epstein J.I., Grignon D., Hes O., Moch H., Montironi R., Tickoo S.T., et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am. J. Surg. Pathol. 2013;37:1469–1489. doi: 10.1097/PAS.0b013e318299f2d1. PubMed DOI

Bhatt J.R., Jewett M.A., Richard P.O., Kawaguchi S., Timilshina N., Evans A., Alibhai S., Finelli A. Multilocular Cystic Renal Cell Carcinoma: Pathological T Staging Makes No Difference to Favorable Outcomes and Should be Reclassified. J. Urol. 2016;196:1350–1355. doi: 10.1016/j.juro.2016.05.118. PubMed DOI

Chen S., Jin B., Xu L., Fu G., Meng H., Liu B., Li J., Xia D. Cystic renal cell carcinoma: A report of 67 cases including 4 cases with concurrent renal cell carcinoma. BMC Urol. 2014;14:87. doi: 10.1186/1471-2490-14-87. PubMed DOI PMC

Li T., Chen J., Jiang Y., Ning X., Peng S., Wang J., He Q., Yang X., Gong K. Multilocular Cystic Renal Cell Neoplasm of Low Malignant Potential: A Series of 76 Cases. Clin Genitourin. Cancer. 2016;14:e553–e557. doi: 10.1016/j.clgc.2016.03.017. PubMed DOI

Suzigan S., López-Beltrán A., Montironi R., Drut R., Romero A., Hayashi T., Gentili A.L.C., Fonseca P.S.P., deTorres I., Billis A., et al. Multilocular cystic renal cell carcinoma: A report of 45 cases of a kidney tumor of low malignant potential. Am. J. Clin. Pathol. 2006;125:217–222. doi: 10.1309/AH6FC77PYR2V6YAY. PubMed DOI

Tretiakova M., Mehta V., Kocherginsky M., Minor A., Shen S.S., Sirintrapun S.J., Yao J.L., Alvarado-Cabrero I., Antic T., Eggener S., et al. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum. Virchows Arch. 2018;473:85–93. doi: 10.1007/s00428-018-2371-8. PubMed DOI

Westerman M.E., Cheville J.C., Lohse C.M., Sharma V., Boorjian S.A., Leibovich B.C., Thompson R.H. Long-Term Outcomes of Patients with Low Grade Cystic Renal Epithelial Neoplasms. Urology. 2019;133:145–150. doi: 10.1016/j.urology.2019.07.017. PubMed DOI

Moch H., Cubilla A.L., Humphrey P.A., Reuter V.E., Ulbright T.M. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur. Urol. 2016;70:93–105. doi: 10.1016/j.eururo.2016.02.029. PubMed DOI

Nassir A., Jollimore J., Gupta R., Bell D., Norman R. Multilocular cystic renal cell carcinoma: A series of 12 cases and review of the literature. Urology. 2002;60:421–427. doi: 10.1016/S0090-4295(02)01742-9. PubMed DOI

Agarwal S., Agrawal U., Mohanty N.K., Saxena S. Multilocular cystic renal cell carcinoma: A case report of a rare entity. Arch. Pathol. Lab. Med. 2011;135:290–292. doi: 10.5858/2010-0243-LE.1. PubMed DOI

Sabhiki A., Abrari A., Sachdev R., Chawla A., Vaidya A. Multilocular cystic renal cell carcinoma: A diagnostic rarity. Indian J. Pathol. Microbiol. 2008;51:457–458. PubMed

Gong K., Zhang N., He Z., Zhou L., Lin G., Na Y. Multilocular cystic renal cell carcinoma: An experience of clinical management for 31 cases. J. Cancer Res. Clin. Oncol. 2008;134:433–437. doi: 10.1007/s00432-007-0302-1. PubMed DOI

Curry N.S., Cochran S.T., Bissada N.K. Cystic renal masses: Accurate Bosniak classification requires adequate renal CT. AJR Am. J. Roentgenol. 2000;175:339–342. doi: 10.2214/ajr.175.2.1750339. PubMed DOI

Bosniak M.A. The current radiological approach to renal cysts. Radiology. 1986;158:1–10. doi: 10.1148/radiology.158.1.3510019. PubMed DOI

Bosniak M.A. Diagnosis and management of patients with complicated cystic lesions of the kidney. AJR Am. J. Roentgenol. 1997;169:819–821. doi: 10.2214/ajr.169.3.9275903. PubMed DOI

Bosniak M.A. The use of the Bosniak classification system for renal cysts and cystic tumors. J. Urol. 1997;157:1852–1853. doi: 10.1016/S0022-5347(01)64883-3. PubMed DOI

Israel G.M., Bosniak M.A. An update of the Bosniak renal cyst classification system. Urology. 2005;66:484–488. doi: 10.1016/j.urology.2005.04.003. PubMed DOI

Hora M., Hes O., Michal M., Boudova L., Chudacek Z., Kreuzberg B., Klecka J. Extensively cystic renal neoplasms in adults (Bosniak classification II or III)-possible common histological diagnoses: Multilocular cystic renal cell carcinoma, cystic nephroma, and mixed epithelial and stromal tumor of the kidney. Int. Urol. Nephrol. 2005;37:743–750. doi: 10.1007/s11255-005-1201-5. PubMed DOI

You D., Shim M., Jeong I.G., Song C., Kim J.K., Ro J.Y., Hong J.H., Ahn H., Kim C.S. Multilocular cystic renal cell carcinoma: Clinicopathological features and preoperative prediction using multiphase computed tomography. BJU Int. 2011;108:1444–1449. doi: 10.1111/j.1464-410X.2011.10247.x. PubMed DOI

Pitra T., Pivovarcikova K., Tupy R., Alaghehbandan R., Barakova T., Travnicek I., Prochazkova K., Klatte T., Chlosta P., Hes O., et al. Magnetic resonance imaging as an adjunct diagnostic tool in computed tomography defined Bosniak IIF-III renal cysts: A multicenter study. World J. Urol. 2018;36:905–911. doi: 10.1007/s00345-018-2176-z. PubMed DOI

Ferreira A.M., Reis R.B., Kajiwara P.P., Silva G.E., Elias J., Muglia V.F. MRI evaluation of complex renal cysts using the Bosniak classification: A comparison to CT. Abdom Radiol. 2016;41:2011–2019. doi: 10.1007/s00261-016-0797-5. PubMed DOI

Clevert D.A., Minaifar N., Weckbach S., Jung E.M., Stock K., Reiser M., Staehler M. Multislice computed tomography versus contrast-enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system. Clin. Hemorheol. Microcirc. 2008;39:171–178. doi: 10.3233/CH-2008-1083. PubMed DOI

Graumann O., Osther S.S., Karstoft J., Hørlyck A., Osther P.J. Bosniak classification system: A prospective comparison of CT, contrast-enhanced US, and MR for categorizing complex renal cystic masses. Acta Radiol. 2015;57:1409–1417. doi: 10.1177/0284185115588124. PubMed DOI

Ignee A., Straub B., Brix D., Schuessler G., Ott M., Dietrich C.F. The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. Clin. Hemorheol. Microcirc. 2010;46:275–290. doi: 10.3233/CH-2010-1352. PubMed DOI

Rübenthaler J., Bogner F., Reiser M., Clevert D.A. Contrast-Enhanced Ultrasound (CEUS) of the Kidneys by Using the Bosniak Classification. Ultraschall Med. 2016;37:234–251. doi: 10.1055/s-0042-104646. PubMed DOI

Shan K., Fu A.B.D.L., Liu N., Cai Q., Fu Q., Liu L., Sun X., Zhang Z. Contrast-enhanced Ultrasound (CEUS) vs contrast-enhanced computed tomography for multilocular cystic renal neoplasm of low malignant potential: A retrospective analysis for diagnostic performance study. Medicine. 2020;99:e23110. doi: 10.1097/MD.0000000000023110. PubMed DOI PMC

Hindman N.M. Imaging of Cystic Renal Masses. Radiol. Clin. N. Am. 2017;55:259–277. doi: 10.1016/j.rcl.2016.10.004. PubMed DOI

Robbin M.L., Lockhart M.E., Barr R.G. Renal imaging with ultrasound contrast: Current status. Radiol. Clin. N. Am. 2003;41:963–978. doi: 10.1016/S0033-8389(03)00070-8. PubMed DOI

Cantisani V., Bertolotto M., Clevert D.A., Correas J.M., Drudi F.M., Fischer T., Gilja O.H., Granata A., Graumann O., Harvey C.J., et al. EFSUMB 2020 Proposal for a Contrast-Enhanced Ultrasound-Adapted Bosniak Cyst Categorization-Position Statement. Ultraschall Med. 2021;42:154–166. doi: 10.1055/a-1300-1727. PubMed DOI

Edney E., Davenport M.S., Curci N., Schieda N., Krishna S., Hindman N., Silverman S.G., Pedrosa I. Bosniak classification of cystic renal masses, version 2019: Interpretation pitfalls and recommendations to avoid misclassification. Abdom. Radiol. 2021;46:2699–2711. doi: 10.1007/s00261-020-02906-8. PubMed DOI PMC

Schieda N., Davenport M.S., Krishna S., Edney E.A., Pedrosa I., Hindman N., Baroni R.H., Curci N.E., Shinagare A., Silverman S.G. Bosniak Classification of Cystic Renal Masses, Version 2019: A Pictorial Guide to Clinical Use. Radiographics. 2022;42:E33. doi: 10.1148/rg.219016. PubMed DOI

Silverman S.G., Pedrosa I., Ellis J.H., Hindman N.M., Schieda N., Smith A.D., Remer E.M., Shinagare A.B., Curci N.E., Raman S.S., et al. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology. 2019;292:475–488. doi: 10.1148/radiol.2019182646. PubMed DOI PMC

Sevcenco S., Spick C., Helbich T.H., Heinz G., Shariat S.F., Klingler H.C., Rauchenwald M., Baltzer P.A. Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography—A systematic review and meta-analysis. Eur. Radiol. 2017;27:2239–2247. doi: 10.1007/s00330-016-4631-9. PubMed DOI PMC

Schoots I.G., Zaccai K., Hunink M.G., Verhagen P.C.M.S. Bosniak Classification for Complex Renal Cysts Reevaluated: A Systematic Review. J. Urol. 2017;198:12–21. doi: 10.1016/j.juro.2016.09.160. PubMed DOI

Israel G.M., Bosniak M.A. Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF) AJR Am. J. Roentgenol. 2003;181:627–633. doi: 10.2214/ajr.181.3.1810627. PubMed DOI

Weibl P., Hora M., Kollarik B., Shariat S.F., Klatte T. Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions. World J. Urol. 2015;33:295–300. doi: 10.1007/s00345-014-1301-x. PubMed DOI

Weibl P., Hora M., Kollarik B., Kalusova K., Pitra T., Remzi M., Hübner W., Balzer P., Klatte T. A practical guide and decision-making protocol forthe management of complex renal cystic masses. Arab. J. Urol. 2017;15:115–122. doi: 10.1016/j.aju.2017.02.001. PubMed DOI PMC

Ljungberg B., Albiges L., Abu-Ghanem Y., Bensalah K., Dabestani S., Montes S.F., Gilles R.H., Hofmann F., Hora M., Kuczyk M.A., et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur. Urol. 2019;75:799–810. doi: 10.1016/j.eururo.2019.02.011. PubMed DOI

Singhai A., Babu S., Verma N., Singh V. Multilocular cystic renal cell carcinoma: A rare entity. BMJ Case Rep. 2013 doi: 10.1136/bcr-2012-008457. PubMed DOI PMC

Kuroda N., Ohe C., Mikami S., Inoue K., Nagashima Y., Cohen R.J., Pan C.-C., Michal M., Hes O. Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol. Histopathol. 2012;27:969–974. PubMed

Montironi R., Lopez-Beltran A., Cheng L., Scarpelli M. Words of wisdom: Re: Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Eur. Urol. 2013;63:400–401. doi: 10.1016/j.eururo.2012.11.017. PubMed DOI

Williamson S.R., Halat S., Eble J.N., Grignon D.J., Lopez-Beltran A., Montironi R., Tan P.-H., Wang M., Maclennan G.T., Baldridge L.A., et al. Multilocular cystic renal cell carcinoma: Similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am. J. Surg. Pathol. 2012;36:1425–1433. doi: 10.1097/PAS.0b013e31825b37f0. PubMed DOI

von Teichman A., Compérat E., Behnke S., Storz M., Moch H., Schraml P. VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma. Mod. Pathol. 2011;24:571–578. doi: 10.1038/modpathol.2010.222. PubMed DOI

Li G., Bilal I., Gentil-Perret A., Feng G., Zhao A., Peoc'h M., Genin C., Tostain J., Gigante M. CA9 as a molecular marker for differential diagnosis of cystic renal tumors. Urol. Oncol. 2012;30:463–468. doi: 10.1016/j.urolonc.2010.04.014. PubMed DOI

Gonzalez M.L., Alaghehbandan R., Pivovarcikova K., Michalova K., Rogala J., Martinek P., Foix M.P., Mundo E.C., Comperat E., Ulamec M., et al. Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells. Histopathology. 2019;74:608–617. doi: 10.1111/his.13791. PubMed DOI

Ostler D.A., Prieto V.G., Reed J.A., Deavers M.T., Lazar A.J., Ivan D. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: An immunohistochemical study of 117 cases. Mod. Pathol. 2010;23:567–573. doi: 10.1038/modpathol.2010.1. PubMed DOI

Kim S.H., Park B., Joo J., Joung J.Y., Seo H.K., Lee K.H., Park W.S., Chung J. Retrospective analysis of 25 immunohistochemical tissue markers for differentiating multilocular cystic renal neoplasm of low malignant potential and multicystic renal cell carcinoma. Histol. Histopathol. 2018;33:589–596. PubMed

Halat S., Eble J.N., Grignon D.J., Lopez-Beltran A., Montironi R., Tan P.H., Wang M., Zhang S., MacLennan G.T., Cheng L. Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod. Pathol. 2010;23:931–936. doi: 10.1038/modpathol.2010.78. PubMed DOI

Raspollini M.R., Castiglione F., Martignoni G., Cheng L., Montironi R., Lopez-Beltran A. Unlike in clear cell renal cell carcinoma, KRAS is not mutated in multilocular cystic clear cell renal cell neoplasm of low potential. Virchows Arch. 2015;467:687–693. doi: 10.1007/s00428-015-1859-8. PubMed DOI

Kim S.H., Park W.S., Chung J. SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change. Investig. Clin. Urol. 2019;60:148–155. doi: 10.4111/icu.2019.60.3.148. PubMed DOI PMC

Delahunt B., Cheville J.C., Martignoni G., Humphrey P.A., Magi-Galluzzi C., McKenney J., Egevad L., Algaba F., Moch H., Grignon D.J., et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am. J. Surg. Pathol. 2013;37:1490–1504. doi: 10.1097/PAS.0b013e318299f0fb. PubMed DOI

Eble J.N., Bonsib S.M. Extensively cystic renal neoplasms: Cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin. Diagn. Pathol. 1998;15:2–20. PubMed

Eble J.N., Sauter G., Epstein J.I., Sesterhenn I.A. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press; Lyon, France: 2004.

Aubert S., Zini L., Delomez J., Biserte J., Lemaitre L., Leroy X. Cystic renal cell carcinomas in adults. Is preoperative recognition of multilocular cystic renal cell carcinoma possible? J. Urol. 2005;174:2115–2119. doi: 10.1097/01.ju.0000181210.72528.ab. PubMed DOI

Hindman N.M., Bosniak M.A., Rosenkrantz A.B., Lee-Felker S., Melamed J. Multilocular cystic renal cell carcinoma: Comparison of imaging and pathologic findings. AJR Am. J. Roentgenol. 2012;198:W20–W26. doi: 10.2214/AJR.11.6762. PubMed DOI

Raspollini M.R., Montagnani I., Montironi R., Cheng L., Martignoni G., Minervini A., Serni S., Nicita G., Carini M., Lopez-Beltran A. A contemporary series of renal masses with emphasis on recently recognized entities and tumors of low malignant potential: A report based on 624 consecutive tumors from a single tertiary center. Pathol. Res. Pract. 2017;213:804–808. doi: 10.1016/j.prp.2017.03.007. PubMed DOI

Rübenthaler J., Paprottka K.J., Marcon J., Reiser M., Clevert D.A. MRI and contrast enhanced ultrasound (CEUS) image fusion of renal lesions. Clin. Hemorheol. Microcirc. 2016;64:457–466. doi: 10.3233/CH-168116. PubMed DOI

Sanz E., Hevia V., Gómez V., Álvarez S., Fabuel J.J., Martínez L., Rodriguez-Patrón R., González-Gordaliza C., Burgos F.-J. Renal Complex Cystic Masses: Usefulness of Contrast-Enhanced Ultrasound (CEUS) in Their Assessment and Its Agreement with Computed Tomography. Curr. Urol. Rep. 2016;17:89. doi: 10.1007/s11934-016-0646-7. PubMed DOI

Katabathina V.S., Garg D., Prasad S.R., Vikram R. Cystic renal neoplasms and renal neoplasms associated with cystic renal diseases in adults: Cross-sectional imaging findings. J. Comput. Assist. Tomogr. 2012;36:659–668. doi: 10.1097/RCT.0b013e31826dba18. PubMed DOI